Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine/fentanyl versus midazolam/fentanyl sedation in uncooperative pediatric dental patients
IRCT20140106016106N7Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Apr 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketamine, fentanyl and midazolam (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Sedative effect of fentanyl + ketamine, Sedative effect of fentanyl + midazolam and 1 more. Started Apr 2019; status: completed.
02
Drugs
ketaminefentanylmidazolam
Beyond the preview
Go deeper on IRCT20140106016106N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140106016106N7.